Physical inactivity in nine European and Central Asian countries: an analysis of national population-based survey results.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
11 10 2021
Historique:
pubmed: 19 8 2021
medline: 11 11 2021
entrez: 18 8 2021
Statut: ppublish

Résumé

Physical inactivity is a major risk factor for non-communicable diseases. However, recent and systematically obtained national-level data to guide policy responses are often lacking, especially in countries in Eastern Europe and Central Asia. This article describes physical inactivity patterns among adults in Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkey and Uzbekistan. Data were collected using the Global Physical Activity Questionnaire drawing nationally representative samples of adults in each country. The national prevalence of physical inactivity was calculated as well as the proportional contribution to total physical activity (PA) during work, transport and leisure-time. An adjusted logistic regression model was applied to analyze the association of age, gender, education, household status and income with physical inactivity. National prevalence of physical inactivity ranged from 10.1% to 43.6%. The highest proportion of PA was registered during work or in the household in most countries, whereas the lowest was during leisure-time in all countries. Physical inactivity was more likely with older age in eight countries, with female gender in three countries, and with living alone in three countries. There was no clear pattern of association with education and income. Prevalence of physical inactivity is heterogeneous across the region. PA during leisure-time contributes minimally to total PA in all countries. Policies and programs that increase opportunities for active travel and leisure-time PA, especially for older adults, women and people living alone will be an essential part of strategies to increase overall population PA.

Sections du résumé

BACKGROUND
Physical inactivity is a major risk factor for non-communicable diseases. However, recent and systematically obtained national-level data to guide policy responses are often lacking, especially in countries in Eastern Europe and Central Asia. This article describes physical inactivity patterns among adults in Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkey and Uzbekistan.
METHODS
Data were collected using the Global Physical Activity Questionnaire drawing nationally representative samples of adults in each country. The national prevalence of physical inactivity was calculated as well as the proportional contribution to total physical activity (PA) during work, transport and leisure-time. An adjusted logistic regression model was applied to analyze the association of age, gender, education, household status and income with physical inactivity.
RESULTS
National prevalence of physical inactivity ranged from 10.1% to 43.6%. The highest proportion of PA was registered during work or in the household in most countries, whereas the lowest was during leisure-time in all countries. Physical inactivity was more likely with older age in eight countries, with female gender in three countries, and with living alone in three countries. There was no clear pattern of association with education and income.
CONCLUSION
Prevalence of physical inactivity is heterogeneous across the region. PA during leisure-time contributes minimally to total PA in all countries. Policies and programs that increase opportunities for active travel and leisure-time PA, especially for older adults, women and people living alone will be an essential part of strategies to increase overall population PA.

Identifiants

pubmed: 34405879
pii: 6354125
doi: 10.1093/eurpub/ckab028
pmc: PMC8504998
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

846-853

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.

Références

Eur J Epidemiol. 2001;17(3):245-53
pubmed: 11680543
J Aging Health. 2002 Nov;14(4):427-51
pubmed: 12391994
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Obes Res. 2004 Jul;12(7):1117-27
pubmed: 15292476
Prev Med Rep. 2015 Dec 04;3:40-5
pubmed: 26844185
Biomed Res Int. 2018 Dec 5;2018:7856823
pubmed: 30627571
J Phys Act Health. 2009 Nov;6(6):790-804
pubmed: 20101923
Lancet. 2017 Dec 16;390(10113):2643-2654
pubmed: 28943267
J Hum Hypertens. 2005 Feb;19(2):145-8
pubmed: 15496966
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
Annu Rev Public Health. 2006;27:297-322
pubmed: 16533119
BMC Public Health. 2016 Aug 04;16:720
pubmed: 27492437
Int J Behav Nutr Phys Act. 2019 Aug 20;16(1):68
pubmed: 31429772
Int J Behav Nutr Phys Act. 2011 Jul 26;8:77
pubmed: 21791105
BMC Public Health. 2019 Dec 12;19(1):1677
pubmed: 31830956
Med Sci Sports Exerc. 2013 Feb;45(2):278-85
pubmed: 22903137
Health Policy. 2018 May;122(5):519-527
pubmed: 29422372
Public Health Nutr. 2013 Nov;16(11):1924-32
pubmed: 23701712
Lancet Public Health. 2019 Aug;4(8):e360
pubmed: 31345750
Am J Prev Med. 2002 Apr;22(3):188-99
pubmed: 11897464
Sports Med. 2012 May 1;42(5):433-47
pubmed: 22512413
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
BMC Public Health. 2013 Sep 08;13:813
pubmed: 24010994
Int J Epidemiol. 2011 Oct;40(5):1382-400
pubmed: 22039197
Int J Behav Nutr Phys Act. 2009 Mar 31;6:21
pubmed: 19335883
Eur J Clin Nutr. 2006 Dec;60(12):1355-66
pubmed: 16788710
PLoS One. 2015 Aug 28;10(8):e0135651
pubmed: 26317865
J Aging Health. 2008 Oct;20(7):767-87
pubmed: 18559963
Int J Environ Res Public Health. 2020 May 21;17(10):
pubmed: 32455832
J Phys Act Health. 2009 May;6(3):269-80
pubmed: 19564654

Auteurs

Stephen Whiting (S)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.
EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.

Romeu Mendes (R)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.
EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.

Karim Abu-Omar (K)

Department of Sport Science and Sport, FAU, Erlangen, Germany.

Peter Gelius (P)

Department of Sport Science and Sport, FAU, Erlangen, Germany.

Anna Crispo (A)

Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy.

Karen McColl (K)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.

Phillipa Simmonds (P)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.

Natalia Fedkina (N)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.

Dianne Andreasyan (D)

National Institute of Health, National Health Information Analytic Centre, National Institute of Health, Yerevan, Armenia.

Hagverdiyev Gahraman (H)

Public Health and Reforms Center of the Ministry of Health, Baku, Azerbaijan.

Tatyana Migal (T)

Department of Health Care Organization of the Ministry of Health, Minsk, Belarus.

Lela Sturua (L)

National Center for Disease Control and Public Health, Tbilisi, Georgia.

Galina Obreja (G)

Department of Social Medicine and Health Management, State University of Medicine and Pharmacy, Chisinau, Republic of Moldova.

Zulfinissio Abdurakhmanova (Z)

Republican Nutrition Center, Dushanbe, Tajikistan.

Ibraeva Nurgul Saparkulovna (IN)

Organization of Medical Care and Medicines Policy, Bishkek, Kyrgyzstan.

Toker Erguder (T)

WHO Country Office in Turkey, Ankara, Turkey.

Banu Ekinci (B)

General Directorate of Public Health, Ministry of Health, Ankara, Turkey.

Bekir Keskinkilic (B)

General Directorate of Public Health, Ministry of Health, Ankara, Turkey.

Shukhrat Shukurov (S)

Central Bureau for the implementation of the Health-3 project, Tashkent, Uzbekistan.

Rustam Yuldashev (R)

Central Bureau for the implementation of the Health-3 project, Tashkent, Uzbekistan.

Nino Berdzuli (N)

WHO Regional Office for Europe, Copenhagen, Denmark.

Ivo Rakovac (I)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.

Joao Breda (J)

WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH